Immunocore's drug KIMMTRAK received treatment approvals in the UK, US, Canada, and Australia.
2 reports, 2 independent
Updated Jul 30
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Immunocore's drug KIMMTRAK received treatment approvals in the UK, US, Canada, and Australia.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Immunocore
UK business
Nothing else this week.
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswireImmunocore to present at upcoming investor conferences Immunocore to present at upcoming investor conferences (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, September 3, 2025) I